These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 16216270)

  • 1. Characterization and HIV-1 fusion inhibitory properties of monoclonal Fabs obtained from a human non-immune phage library selected against diverse epitopes of the ectodomain of HIV-1 gp41.
    Louis JM; Bewley CA; Gustchina E; Aniana A; Clore GM
    J Mol Biol; 2005 Nov; 353(5):945-51. PubMed ID: 16216270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Covalent trimers of the internal N-terminal trimeric coiled-coil of gp41 and antibodies directed against them are potent inhibitors of HIV envelope-mediated cell fusion.
    Louis JM; Nesheiwat I; Chang L; Clore GM; Bewley CA
    J Biol Chem; 2003 May; 278(22):20278-85. PubMed ID: 12654905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Affinity maturation by targeted diversification of the CDR-H2 loop of a monoclonal Fab derived from a synthetic naïve human antibody library and directed against the internal trimeric coiled-coil of gp41 yields a set of Fabs with improved HIV-1 neutralization potency and breadth.
    Gustchina E; Louis JM; Frisch C; Ylera F; Lechner A; Bewley CA; Clore GM
    Virology; 2009 Oct; 393(1):112-9. PubMed ID: 19695655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A monoclonal Fab derived from a human nonimmune phage library reveals a new epitope on gp41 and neutralizes diverse human immunodeficiency virus type 1 strains.
    Gustchina E; Louis JM; Lam SN; Bewley CA; Clore GM
    J Virol; 2007 Dec; 81(23):12946-53. PubMed ID: 17898046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequestering of the prehairpin intermediate of gp41 by peptide N36Mut(e,g) potentiates the human immunodeficiency virus type 1 neutralizing activity of monoclonal antibodies directed against the N-terminal helical repeat of gp41.
    Gustchina E; Bewley CA; Clore GM
    J Virol; 2008 Oct; 82(20):10032-41. PubMed ID: 18667502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and properties of N(CCG)-gp41, a chimeric gp41 molecule with nanomolar HIV fusion inhibitory activity.
    Louis JM; Bewley CA; Clore GM
    J Biol Chem; 2001 Aug; 276(31):29485-9. PubMed ID: 11418583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding of HIV-1 gp41-directed neutralizing and non-neutralizing fragment antibody binding domain (Fab) and single chain variable fragment (ScFv) antibodies to the ectodomain of gp41 in the pre-hairpin and six-helix bundle conformations.
    Louis JM; Aniana A; Lohith K; Sayer JM; Roche J; Bewley CA; Clore GM
    PLoS One; 2014; 9(8):e104683. PubMed ID: 25105806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural basis of HIV-1 neutralization by affinity matured Fabs directed against the internal trimeric coiled-coil of gp41.
    Gustchina E; Li M; Louis JM; Anderson DE; Lloyd J; Frisch C; Bewley CA; Gustchina A; Wlodawer A; Clore GM
    PLoS Pathog; 2010 Nov; 6(11):e1001182. PubMed ID: 21085615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human antibody responses to HIV type 1 glycoprotein 41 cloned in phage display libraries suggest three major epitopes are recognized and give evidence for conserved antibody motifs in antigen binding.
    Binley JM; Ditzel HJ; Barbas CF; Sullivan N; Sodroski J; Parren PW; Burton DR
    AIDS Res Hum Retroviruses; 1996 Jul; 12(10):911-24. PubMed ID: 8798976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complexes of neutralizing and non-neutralizing affinity matured Fabs with a mimetic of the internal trimeric coiled-coil of HIV-1 gp41.
    Gustchina E; Li M; Ghirlando R; Schuck P; Louis JM; Pierson J; Rao P; Subramaniam S; Gustchina A; Clore GM; Wlodawer A
    PLoS One; 2013; 8(11):e78187. PubMed ID: 24244293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design of a novel peptide inhibitor of HIV fusion that disrupts the internal trimeric coiled-coil of gp41.
    Bewley CA; Louis JM; Ghirlando R; Clore GM
    J Biol Chem; 2002 Apr; 277(16):14238-45. PubMed ID: 11859089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody elicited against the gp41 N-heptad repeat (NHR) coiled-coil can neutralize HIV-1 with modest potency but non-neutralizing antibodies also bind to NHR mimetics.
    Nelson JD; Kinkead H; Brunel FM; Leaman D; Jensen R; Louis JM; Maruyama T; Bewley CA; Bowdish K; Clore GM; Dawson PE; Frederickson S; Mage RG; Richman DD; Burton DR; Zwick MB
    Virology; 2008 Jul; 377(1):170-83. PubMed ID: 18499210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selection of gp41-mediated HIV-1 cell entry inhibitors from biased combinatorial libraries of non-natural binding elements.
    Ferrer M; Kapoor TM; Strassmaier T; Weissenhorn W; Skehel JJ; Oprian D; Schreiber SL; Wiley DC; Harrison SC
    Nat Struct Biol; 1999 Oct; 6(10):953-60. PubMed ID: 10504731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential inhibition of HIV-1 and SIV envelope-mediated cell fusion by C34 peptides derived from the C-terminal heptad repeat of gp41 from diverse strains of HIV-1, HIV-2, and SIV.
    Gustchina E; Hummer G; Bewley CA; Clore GM
    J Med Chem; 2005 Apr; 48(8):3036-44. PubMed ID: 15828842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of critical antibody-binding sites in the HIV-1 gp41 six-helix bundle core as potential targets for HIV-1 fusion inhibitors.
    Li J; Chen X; Huang J; Jiang S; Chen YH
    Immunobiology; 2009; 214(1):51-60. PubMed ID: 19159827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A salt bridge between an N-terminal coiled coil of gp41 and an antiviral agent targeted to the gp41 core is important for anti-HIV-1 activity.
    Jiang S; Debnath AK
    Biochem Biophys Res Commun; 2000 Apr; 270(1):153-7. PubMed ID: 10733920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Covalent stabilization of coiled coils of the HIV gp41 N region yields extremely potent and broad inhibitors of viral infection.
    Bianchi E; Finotto M; Ingallinella P; Hrin R; Carella AV; Hou XS; Schleif WA; Miller MD; Geleziunas R; Pessi A
    Proc Natl Acad Sci U S A; 2005 Sep; 102(36):12903-8. PubMed ID: 16129831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Competitive antigen panning for selection of HIV-1 neutralizing human monoclonal antibodies specific for gp41.
    Zhang MY; Dimitrov DS
    Methods Mol Biol; 2009; 525():175-86, xv. PubMed ID: 19252830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A conformation-specific monoclonal antibody reacting with fusion-active gp41 from the human immunodeficiency virus type 1 envelope glycoprotein.
    Jiang S; Lin K; Lu M
    J Virol; 1998 Dec; 72(12):10213-7. PubMed ID: 9811763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Identification of human monoclonal HIV-1-neutralizing antibodies from phage antibody library by cell-based screening].
    Zhang N; Man L; Sun JP; Meng JZ; He YX
    Bing Du Xue Bao; 2013 Sep; 29(5):471-9. PubMed ID: 24386834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.